ACCC’s loss in Pfizer misuse of market power case to stand

Competition & Consumer Protection 2018-10-19 2:27 pm By Cat Fredenburgh | Melbourne

The High Court has dismissed the ACCC’s bid to appeal a Full Federal Court decision upholding a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.